[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Biopharma_Watch "Top Market Movers: Positive News Full Access: $NGNE 29.10$ XXXXX% October X 2025 Neurogene to Participate in H.C. Wainwright Genetic Medicines Virtual Conference"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XXX engagements

"Latest catalysts: $TNXP Catalyst Date - 2025-10-15 Drug - TNX-801 (Mpox Vaccine) Treatment - Mpox Smallpox"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1118 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $BRKR 29.35$ -XXXXX% September X 2025 Bruker Announces Pricing of Public Offering of $XXX Million of XXXXX% Mandatory Convertible Preferred Stock"
X Link @Biopharma_Watch 2025-09-04T13:38Z 1118 followers, XXX engagements

"Top Market Movers: Positive News Full Access: $BJDX 3.74$ XXXXX% October XX 2025 Bluejay Diagnostics Announces Closing of $XXX Million Private Placement Priced At-The-Market Under Nasdaq Rules"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1118 followers, XXX engagements

"$BJDX 2.86$ -XXXXX% October XX 2025 Bluejay Diagnostics Announces $XXX Million Private Placement Priced At-the-Market Under Nasdaq Rules"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1115 followers, XXX engagements

"$EYPT 12.00$ -XXXX% October XX 2025 EyePoint Announces Pricing of Public Offering"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1118 followers, XX engagements

"$STTK 2.46$ XXXX% October X 2025 Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel"
X Link @Biopharma_Watch 2025-10-03T15:45Z 1115 followers, XXX engagements

"$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XX engagements

"Latest catalysts: $STTK Catalyst Date - 2025-10-08 Drug - SL-325 (Death Receptor X blocking antibody) Treatment - Inflammatory bowel disease (IBD) inflammatory and immune-related diseases"
X Link @Biopharma_Watch 2025-10-08T15:45Z 1115 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $QNRX 16.54$ -XXXXX% October XX 2025 Quoin Pharmaceuticals Announces Private Placement Financing of Up to $XXXXX Million"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1116 followers, XXX engagements

"$OCUL Catalyst Date - 2025-10-16 Drug - AXPAXLI (OTX-TKI) Treatment - wet age-related macular degeneration (wet AMD)"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1118 followers, XXX engagements

"$DYN Catalyst Date - 2025-10-08 Drug - zeleciment basivarsen (z-basivarsen formerly known as DYNE-101) Treatment - myotonic dystrophy type X (DM1)"
X Link @Biopharma_Watch 2025-10-08T15:45Z 1116 followers, XX engagements

"$APM 1.45$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1116 followers, XX engagements

"$ABT 127.61$ -XXXX% October XX 2025 Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1118 followers, XX engagements

"Top Market Movers: Positive News Full Access: $CGEM 7.84$ XXXX% October XX 2025 Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1118 followers, XXX engagements

"$INSP 77.05$ XXXX% October XX 2025 Inspire Medical Systems Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1118 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $BCAX 17.11$ -XXXX% October XX 2025 Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1118 followers, XX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $BON - 1.5M - 41.1M - XXXXX $TRML - 486.6K - 8.0M - XXXXX $XLO - 629.4K - 6.3M - 9.98"
X Link @Biopharma_Watch 2025-09-09T15:45Z 1115 followers, XXX engagements

"$GANX Catalyst Date - 2025-10-14 Drug - GT-02287 (allosteric enzyme modulator) Treatment - Parkinson's disease (PD) with or without a GBA1 mutation"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1116 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $SSKN 1.91$ -XXXXX% October XX 2025 Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma Mycosis Fungoides"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1118 followers, XX engagements

"Top Market Movers: Negative News Full Access: $GTBP 0.74$ -XXXXX% October X 2025 GT Biopharma Provides Enrollment Update on GTB-3650 Phase X Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Ma"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"
X Link @Biopharma_Watch 2025-10-10T15:45Z 1118 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $ACTU 6.97$ -XXXXX% September XX 2025 Actuate Therapeutics Announces Proposed Public Offering of Common Stock"
X Link @Biopharma_Watch 2025-09-10T15:45Z 1115 followers, XXX engagements

"$ACXP 7.40$ -XXXX% October XX 2025 Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XX engagements

"$BJDX 2.86$ -XXXXX% October XX 2025 Bluejay Diagnostics Announces Closing of $XXX Million Private Placement Priced At-The-Market Under Nasdaq Rules"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1115 followers, XX engagements

"Latest catalysts: $GANX Catalyst Date - 2025-10-14 Drug - GT-02287 (allosteric enzyme modulator) Treatment - Parkinson's disease (PD) with or without a GBA1 mutation"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1118 followers, XXX engagements

"Latest catalysts: $GHRS Catalyst Date - 2025-10-13 Drug - GH001 (mebufotenin) Treatment - Treatment-resistant depression (TRD)"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1118 followers, XXX engagements

"$SYRE 20.69$ XXXX% October XX 2025 Spyre Therapeutics Announces Pricing of $XXXXX Million Public Offering of Common Stock"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1118 followers, XX engagements

"Latest catalysts: $VERA Catalyst Date - 4Q 2025 Drug - Atacicept Treatment - IgAN (Immunoglobulin A Nephropathy)"
X Link @Biopharma_Watch 2025-10-01T15:45Z 1115 followers, XXX engagements

"Latest catalysts: $RVPH Catalyst Date - 2025-10-10 Drug - brilaroxazine (RP5063) Treatment - schizophrenia"
X Link @Biopharma_Watch 2025-10-10T15:45Z 1115 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $ENVB 0.70$ -XXXXX% October X 2025 Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials"
X Link @Biopharma_Watch 2025-10-03T15:45Z 1115 followers, XXX engagements

"$RNA 46.84$ -XXXX% October XX 2025 Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026"
X Link @Biopharma_Watch 2025-10-14T15:45Z 1118 followers, XXX engagements

"Latest catalysts: $SGMT Catalyst Date - 2025-10-09 Drug - denifanstat (selective FASN inhibitor) Treatment - metabolic dysfunction associated steatohepatitis (MASH)"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XXX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $TCRT - 735.5K - 20.6M - XXXXX $ATHE - 140.6K - 3.7M - XXXXX $BDRX - 176.7K - 4.0M - 22.51"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1118 followers, XXX engagements

"$PFE 26.98$ XXXX% October XX 2025 Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025"
X Link @Biopharma_Watch 2025-10-01T15:45Z 1115 followers, XX engagements

"$DYN 12.65$ XXXX% September XX 2025 Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy"
X Link @Biopharma_Watch 2025-09-30T15:45Z 1112 followers, XX engagements

"$APGE 51.65$ XXXX% October X 2025 Apogee Therapeutics Inc. Announces Pricing of $XXX Million Underwritten Public Offering"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1115 followers, XX engagements

"$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)"
X Link @Biopharma_Watch 2025-10-10T15:45Z 1115 followers, XXX engagements

"$XRAY 12.68$ -XXXX% October X 2025 Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization"
X Link @Biopharma_Watch 2025-10-06T15:45Z 1116 followers, XXX engagements

"Top Market Movers: Positive News Full Access: $ADXN 10.17$ XXXXX% September XX 2025 Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update"
X Link @Biopharma_Watch 2025-09-30T15:45Z 1115 followers, XXX engagements